sphingosine-kinase and Shock--Septic

During sepsis, activation of phagocytes leads to the overproduction of proinflammatory cytokines, causing systemic inflammation. Despite substantial information regarding the underlying molecular mechanisms that lead to sepsis, several elements in the pathway remain to be elucidated. We found that the enzyme sphingosine kinase 1 (SphK1) is up-regulated in stimulated human phagocytes and in peritoneal phagocytes of patients with severe sepsis. Blockade of SphK1 inhibited phagocyte production of endotoxin-induced proinflammatory cytokines. We observed protection against sepsis in mice treated with a specific SphK1 inhibitor that was enhanced by treatment with a broad-spectrum antibiotic. These results demonstrated a critical role for SphK1 in endotoxin signaling and sepsis-induced inflammatory responses and suggest that inhibition of SphK1 is a potential therapy for septic shock.

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bacterial Proteins; Cytokines; Endotoxins; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Inflammation; Lipopolysaccharides; Lipoproteins; Macrophages; Macrophages, Peritoneal; Male; Mice; Middle Aged; Neutrophils; NF-kappa B; Peritonitis; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase C-delta; RNA Interference; Sepsis; Shock, Septic; Signal Transduction; Up-Regulation; Young Adult